NEW YORK, Oct. 27, 2021 /PRNewswire/ -- The testosterone replacement therapy market size is expected to increase by USD 113.54 million from 2019 to 2024, registering a CAGR of almost 1%, according to the latest research report from Technavio. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The testosterone replacement therapy market is segmented by product (injectables, topicals, and others) and geography (North America, Europe, Asia, and ROW).
The testosterone replacement therapy market report covers insights on major trends, key growth drivers, and challenges impacting the overall growth of the market. The report identifies initiatives to increase awareness on disease among population and the rise in chronic diseases as some of the major factors driving the growth of the market.
The testosterone replacement therapy market covers the following areas:
Endocrinology Drugs Market: The endocrinology drugs market has been segmented by therapy area (diabetes drugs, hGH, thyroid hormone disorders, and others) and geography (North America, Europe, Asia, and ROW). Download Free Sample Report
Thyroid Gland Disorder Treatment Market: The thyroid gland disorder treatment market has been segmented by type (hypothyroidism and hyperthyroidism) and geography (North America, Europe, Asia, and ROW). Download Free Sample Report
Testosterone Replacement Therapy Market Scope
Growth momentum & CAGR
Decelerate at a CAGR of almost 1%
Market growth 2020-2024
USD 113.54 million
YoY growth (%)
North America, Europe, Asia, and ROW
Performing market contribution
North America at 53%
Key consumer countries
US, UK, Germany, Japan, and China
Leading companies, competitive strategies, consumer engagement scope
AbbVie Inc., Acerus Pharmaceuticals Corp., Antares Pharma Inc., Bayer AG, Clarus Therapeutics Inc., Eli Lilly and Co., Endo International Plc, Ferring Pharmaceuticals AS, Novartis AG, and Pfizer Inc.
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for forecast period
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.